Cancer

Cancer

Cancer research

Clinical Trials

Performance of clinical trials is a departmental priority. The department and affiliated programs are conducting investigational studies of treatments for genitourinary cancer and other conditions with the goal of improving diagnosis, treatment, and follow-up of urologic disease. Learn more at the Helen Diller Family Comprehensive Cancer Center.

Learn More

UCSF is internationally known for its research in prostate and other urological cancers. Our department conducts basic scientific work to analyze and categorize different types of prostate cancer and the health risks they pose. Our faculty lead large epidemiological studies on dietary and other lifestyle interventions that may help reduce the risk of the disease. UCSF Urology also heads CaPSURE™, a multicenter longitudinal study of men with prostate cancer.

In addition to our work in prostate cancer, we have important research programs in bladder, renal and other urological cancers. The department conducts clinical trials of new treatments for genitourinary cancers, coordinated through the urologic clinical and translational science program. We also maintain a urologic oncology database, which provides a valuable repository of information to guide future investigations. Many of our faculty maintain research laboratories at UCSF, where they conduct basic science investigations in their areas of expertise.

Cancer News & Highlights

North Bay writer Mark G. Epstein recently published a story in the St. Helena Star about potential confusion when a patient deciphers the U.S. Preventive Services Task Force guidelines for prostate...
Luke Gilbert, PhD joins UCSF Urology as Assistant Professor in the Helen Diller Family Comprehensive Cancer Center, bringing with him a rigorous training in cancer biology, synthetic biology and...
For a third consecutive year, rankings of the National Institutes of Health (NIH) biomedical research funding put UCSF in first place for urology funding.  According to the Blue Ridge Institute for...
Dr. Cooperberg received the Marin Prostate Cancer Information and Support Group 2016 physician award at their February 2017 meeting.  The following was written by Stan Rosenfeld, support group leader...
UCSF is leading the United States evaluation of a new imaging technique that is helping patients and physicians better target prostate cancer treatment. Called PSMA-PET, it is especially useful in...
Richards Lyon, MD, UCSF clinical faculty member and inventor, leaves a legacy of compassionate care and pioneering inventions from a lifetime of serving others.  He died on December 7th 2016 of...
Postoperative radiotherapy can play in important role in the treatment of prostate cancer, but refining patient selection could improve outcomes and spare patients unnecessary toxicity. A UCSF team...